Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Will the real multiple sclerosis please stand up?
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP.
Effects of a 4-month Ananda Yoga Program on Physical and Mental Health Outcomes for Persons With Multiple Sclerosis.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus.
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.

Pages